Citadel Advisors
CLRB icon

Citadel Advisors’s Cellectar Biosciences CLRB Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-343,258
Closed -$108K 5958
2025
Q1
$108K Buy
+343,258
New +$108K ﹤0.01% 5125
2024
Q4
Sell
-303
Closed -$648 6076
2024
Q3
$648 Sell
303
-49,924
-99% -$107K ﹤0.01% 5645
2024
Q2
$126K Sell
50,227
-67,462
-57% -$169K ﹤0.01% 4863
2024
Q1
$468K Buy
117,689
+48,682
+71% +$194K ﹤0.01% 3985
2023
Q4
$191K Buy
+69,007
New +$191K ﹤0.01% 4628
2023
Q3
Sell
-30,790
Closed -$60K 5934
2023
Q2
$60K Buy
+30,790
New +$60K ﹤0.01% 4933
2023
Q1
Sell
-18,670
Closed -$31.9K 5989
2022
Q4
$31.9K Buy
+18,670
New +$31.9K ﹤0.01% 5418
2022
Q3
Sell
-68,990
Closed -$28K 5966
2022
Q2
$28K Buy
+68,990
New +$28K ﹤0.01% 5648
2022
Q1
Sell
-164,576
Closed -$109K 6427
2021
Q4
$109K Buy
+164,576
New +$109K ﹤0.01% 5855
2021
Q1
Sell
-34,200
Closed -$71K 6309
2020
Q4
$71K Buy
+34,200
New +$71K ﹤0.01% 4778
2020
Q2
Sell
-12,155
Closed -$15K 4698
2020
Q1
$15K Buy
+12,155
New +$15K ﹤0.01% 4695
2019
Q2
Sell
-17,760
Closed -$42K 4681
2019
Q1
$42K Buy
17,760
+3,166
+22% +$7.49K ﹤0.01% 4273
2018
Q4
$23K Buy
+14,594
New +$23K ﹤0.01% 4229
2018
Q3
Sell
-56,299
Closed -$35K 4331
2018
Q2
$35K Buy
+56,299
New +$35K ﹤0.01% 3956
2018
Q1
Sell
-14,215
Closed -$19K 4014
2017
Q4
$19K Buy
+14,215
New +$19K ﹤0.01% 3772
2017
Q2
Sell
-18,990
Closed -$43K 3705
2017
Q1
$43K Buy
+18,990
New +$43K ﹤0.01% 3423